お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
658970

ゲノム編集の世界市場の分析と予測

Global Genome Editing Market Research and Forecast 2018-2023

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
ゲノム編集の世界市場の分析と予測
出版日: 2018年06月05日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のゲノム編集の関連市場について分析し、技術の概要や市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、技術別・用途別・エンドユーザー別・地域別の市場動向の見通し (今後7年間分)、最新の市場競争状況、主要企業のプロファイルなどを調査しております。

第1章 分析概要

第2章 市場の概略と考察

  • 定義
  • アナリストの見解と現在の市場動向
    • 分析のポイント
    • 提言
    • 結論
  • 世界各国の規制状況 (米国、欧州、中国、インドなど)
  • 特許分析

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場区分

  • 世界のゲノム編集市場:技術別
    • CRISPRベースのゲノム編集
    • TALENベースのゲノム編集
    • ZFN (Zinc Finger Nucleases)
    • その他 (トランスポゾン、遺伝子組み換えアデノ随伴ウイルス (RAAV)、ホーミング・エンドヌクレアーゼ/メガヌクレアーゼ)
  • 世界のゲノム編集市場:用途別
    • 細胞株エンジニアリング
    • 遺伝子工学
      • 植物遺伝子工学
      • 動物遺伝子工学
    • その他
  • 世界のゲノム編集市場:エンドユーザー別
    • バイオテクノロジー企業/製薬企業
    • CRO (医薬品開発業務受託機関)
    • 研究機関
    • その他

第5章 競争環境

  • 主要企業の分析
  • 市場戦略の分析

第6章 地域別分析

  • 北米市場 (米国、カナダ)
  • 欧州市場 (英国、ドイツ、イタリア、スペイン、フランスなど)
  • アジア太平洋地域市場 (インド、中国、日本など)
  • 他の国々 (RoW) の市場

第7章 企業プロファイル

  • AGENOVIR CORP
  • BENCHLING, INC.
  • CARIBOU BIOSCIENCES, INC.
  • CRISPR THERAPEUTICS INC.
  • EDITAS MEDICINE INC.
  • EGENESIS BIO
  • EXONICS THERAPEUTICS, INC.
  • GENSCRIPT
  • HORIZON DISCOVERY GROUP
  • INTEGRATED DNA TECHNOLOGIES, INC.
  • INTELLIA THERAPEUTICS, INC.
  • KADMON HOLDINGS, INC.
  • LONZA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • NIGHTSTAR THERAPEUTICS PLC
  • ORIGENE TECHNOLOGIES, INC.
  • POSEIDA THERAPEUTICS, INC.
  • SANGAMO THERAPEUTICS, INC.
  • SYNTHEGO CORP
  • THERMO FISHER SCIENTIFIC, INC.
  • TOCAGEN, INC.
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • VOYAGER THERAPEUTICS, INC.
図表

List of Tables

  • TABLE # 1 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL CRISPR-BASED GENOME EDITING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL TALEN-BASED GENOME EDITING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL ZINC FINGER NUCLEASES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL CELL LINE ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL PLANT GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL ANIMAL GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 12 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
  • TABLE # 13 GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 14 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 15 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 16 GLOBAL OTHERS END USER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 17 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 18 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 19 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
  • TABLE # 20 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
  • TABLE # 21 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
  • TABLE # 22 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 23 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
  • TABLE # 24 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 25 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
  • TABLE # 26 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 27 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
  • TABLE # 28 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 29 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
  • TABLE # 30 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
  • TABLE # 31 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 32 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL GENOME EDITING MARKET SHARE BY TECHNOLOGIES, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL GENOME EDITING MARKET SHARE BY APPLICATION, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL GENOME EDITING MARKET SHARE BY END USER, 2017 VS 2023 (%)
  • FIGURE # 4 US GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 5 CANADA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 UK GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 FRANCE GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 GERMANY GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 ITALY GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 SPAIN GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 ROE GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 INDIA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 CHINA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 JAPAN GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 ROAPAC GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 REST OF THE WORLD GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018285

Genome editing market is technique in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. It has broad range of applications in cell line engineering, genetic engineering, plant genetic engineering, animal genetic engineering and other applications. Further, the technologies used for the genomics editing includes CRISPR-based genome editing, TALEN-based genome editing, zinc finger nucleases and other technologies. The genomics editing market is significantly growing as government is providing funding for genome editing research to various companies such as Caribou Biosciences, Inc., CRISPR Therapeutics Inc. and Editas Medicine Inc.

CRISPR/Cas systems rely upon CRISPR-associated (Cas) proteins and have the potential to carry out alter gene expression or genome editing functions. The CRISPR-Cas9 genome editing systems components can be combined in various ways for several gene editing applications. CRISPR-Cas Systems has wide application in Gene silencing, DNA-free CRISPR-Cas9 gene editing, and Homology-directed repair (HDR). CRISPR-Cas systems products include CRISPR-Cas9 Gene Editing, CRISPR Guide RNA, Cas9 Nuclease, CRISPR Controls and Detection Primers, and CRISPR-Cas9 Screening Libraries.

On the basis of geography, North America is considered to be dominating region with the highest market share and is expected to sustain its dominance during the forecast period as well. This is mainly due to the research grants and funding by government institutes and increasing genome editing application for the treatment of cancer. The key driving forces expected to boost the market of genomics editing in North America are increasing prevalence of cancer and infectious diseases and increasing trend of personalized medicine. Furthermore, Europe region is also considered to be one of major region mainly due to the presence of a large number of academic institutes and availability of funding for life science research. APAC is expected to be the fastest growing region due the government initiatives to support healthcare research and crop research initiatives in the region. The report includes detailed market overview, market segmentation, market determinants, geographical analysis, strategic recommendations, company profiling, patent analysis, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Key players of genomics editing market include Exonics Therapeutics, Inc., Genscript, Horizon Discovery Group, Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Kadmon Holdings, Inc., Lonza, Merck KGaA, New England Biolabs, Nightstar Therapeutics PLC, Origene Technologies, Inc. These market players are increasingly competing against each other by adopting different market strategies such as merger & acquisition, partnership & collaboration and so on. The research and development for innovative gene editing technology will strengthen the competitive environment of the market.

Research Methods and Tools:

To derive the number, the market is analysed by referring annual report of each genomics editing diagnosis and treatment provider. Annual reports of the companies provide deep knowledge about the revenue in a particular region and other prospects. Furthermore, an overview of dominating and fastest growing segment market share is also derived on the basis of information provided by annual reports of the company. Beside this, geographical locations of major market player are analysed. Expansion or acquisition of manufacturing unit in a particular region has been taken into consideration for market estimation. The US, European countries, Japan, China, India and Brazil are the major location taken in to consideration.

THE REPORT COVERS:

  • Comprehensive research methodology of global Genome editing market.
  • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global genome editing market.
  • Insights about market determinants which are stimulating the global genome editing market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

CHAPTER 1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATIONS
      • 2.3.1.1. UNITED STATES
      • 2.3.1.2. EUROPEAN UNION
      • 2.3.1.3. CHINA
      • 2.3.1.4. INDIA
  • 2.4. PATENT ANALYSIS

CHAPTER 3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. INCREASING GENOME EDITING RESEARCH AND DEVELOPMENT INITIATIVE PROGRAM
    • 3.1.2. RISING FUNDING FOR GENOME EDITING RESEARCH
    • 3.1.3. APPLICATION OF GENOME EDITING IN AGRICULTURE
    • 3.1.4. INCREASING PREVALENCE OF CANCER AND INFECTIOUS DISEASES
    • 3.1.5. INCREASING TREND OF PERSONALIZED MEDICINE
  • 3.2. RESTRAINTS
    • 3.2.1. HIGH COST OF GENOME EDITING INSTRUMENTS AND REAGENTS
    • 3.2.2. LACK OF PROFESSIONAL RESEARCHER
    • 3.2.3. TOUGH REGULATORY APPROVALS
  • 3.3. OPPORTUNITIES
    • 3.3.1. ADVANCEMENTS IN GENOME EDITING
    • 3.3.2. LARGE NUMBER OF PIPELINE PRODUCTS
    • 3.3.3. EMERGING MARKET

CHAPTER 4. MARKET SEGMENTATION

  • 4.1. GLOBAL GENOME EDITING MARKET, BY TECHNOLOGIES
    • 4.1.1. CRISPR-BASED GENOME EDITING
    • 4.1.2. TALEN-BASED GENOME EDITING
    • 4.1.3. ZINC FINGER NUCLEASES
    • 4.1.4. OTHER (TRANSPOSONS, RECOMBINANT ADENO-ASSOCIATED VIRUS OR RAAV, HOMING ENDONUCLEASES OR MEGANUCLEASES)
  • 4.2. GLOBAL GENOME EDITING MARKET, BY APPLICATION
    • 4.2.1. CELL LINE ENGINEERING
    • 4.2.2. GENETIC ENGINEERING
      • 4.2.2.1. PLANT GENETIC ENGINEERING
      • 4.2.2.2. ANIMAL GENETIC ENGINEERING
    • 4.2.3. OTHER APPLICATIONS
  • 4.3. GLOBAL GENOME EDITING MARKET BY END USERS
    • 4.3.1. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
    • 4.3.2. CONTRACT RESEARCH ORGANIZATIONS
    • 4.3.3. RESEARCH INSTITUTES
    • 4.3.4. OTHERS

CHAPTER 5. COMPETITIVE LANDSCAPE

  • 5.1. KEY COMPANY ANALYSIS
  • 5.2. KEY STRATEGIC ANALYSIS

CHAPTER 6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICAN
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. U.K
    • 6.2.2. GERMANY
    • 6.2.3. ITALY
    • 6.2.4. SPAIN
    • 6.2.5. FRANCE
    • 6.2.6. ROE
  • 6.3. ASIA PACIFIC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
    • 6.3.4. ROAPAC
  • 6.4. REST OF THE WORLD

CHAPTER 7. COMPANY PROFILES

  • 7.1. AGENOVIR CORP
  • 7.2. BENCHLING, INC.
  • 7.3. CARIBOU BIOSCIENCES, INC.
  • 7.4. CRISPR THERAPEUTICS INC.
  • 7.5. EDITAS MEDICINE INC.
  • 7.6. EGENESIS BIO
  • 7.7. EXONICS THERAPEUTICS, INC.
  • 7.8. GENSCRIPT
  • 7.9. HORIZON DISCOVERY GROUP
  • 7.10. INTEGRATED DNA TECHNOLOGIES, INC.
  • 7.11. INTELLIA THERAPEUTICS, INC.
  • 7.12. KADMON HOLDINGS, INC.
  • 7.13. LONZA
  • 7.14. MERCK KGAA
  • 7.15. NEW ENGLAND BIOLABS
  • 7.16. NIGHTSTAR THERAPEUTICS PLC
  • 7.17. ORIGENE TECHNOLOGIES, INC.
  • 7.18. POSEIDA THERAPEUTICS, INC.
  • 7.19. SANGAMO THERAPEUTICS, INC.
  • 7.20. SYNTHEGO CORP
  • 7.21. THERMO FISHER SCIENTIFIC, INC.
  • 7.22. TOCAGEN, INC.
  • 7.23. TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • 7.24. VOYAGER THERAPEUTICS, INC.
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.